CYP2J2∗7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients

• Main Authors: Jemal Hussien Ahmed (Author), Eyasu Makonnen (Author), Getnet Yimer (Author), Daniel Seifu (Author), Abebe Bekele (Author), Mathewos Assefa (Author), Abraham Aseffa (Author), Rawleigh Howe (Author), Alan Fotoohi (Author), Moustapha Hassan (Author), Eleni Aklillu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Chemotherapy-induced hematologic toxicity is the primary reasons of dose reductions and/or delays, low relative dose intensity (RDI), and predicts anticancer response. We investigated the incidence and predictors of chemotherapy-induced hematologic toxicities and reduced RDI in Ethiopian breast canc...